NCT03207867 2024-10-09A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin LymphomaNovartisPhase 2 Terminated315 enrolled 73 charts
NCT04193293 2023-09-21A Study of Duvelisib in Combination With Pembrolizumab in Head and Neck CancerSecuraBioPhase 1/2 Terminated2 enrolled
NCT02404441 2022-08-03Phase I/II Study of PDR001 in Patients With Advanced MalignanciesNovartisPhase 1/2 Completed319 enrolled 41 charts
NCT02605967 2022-02-10Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal CarcinomaNovartisPhase 2 Completed122 enrolled 28 charts